We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $375M
1-Year Est. Return 72.65%
This Fund
S&P 500
This Quarter Est. Return
+12.39%
1 Year Est. Return
+72.65%
3 Year Est. Return
+156.29%
5 Year Est. Return
+218.72%
10 Year Est. Return
–
AUM
$184M
AUM Growth
+$701K
Cap. Flow
-$16.4M
Cap. Flow %
-8.91%
Top 10 Hldgs %
51.23%
Holding
107
New
12
Increased
18
Reduced
32
Closed
25

Top Buys

Rank Stock Value
1
RVNC
Revance Therapeutics, Inc.
RVNC
+$1.89M
2
BABA icon
Alibaba
BABA
+$1.31M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.09M
4
LFCR icon
Lifecore Biomedical
LFCR
+$965K
5
YETI icon
Yeti Holdings
YETI
+$443K

Top Sells

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$2.33M
2
ABBV icon
AbbVie
ABBV
+$1.75M
3
GDXJ icon
VanEck Junior Gold Miners ETF
GDXJ
+$1.28M
4
T icon
AT&T
T
+$1M
5
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$986K

Sector Composition

Rank Sector Weight
1 Healthcare 32.01%
2 Technology 17.2%
3 Communication Services 6.8%
4 Consumer Discretionary 4.09%
5 Financials 3.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QQQ icon
1
PUT
Invesco QQQ Trust
QQQ
$453B
$22.5M 12.22%
55,000
-13,500
-20% -$5.12M
MU icon
2
Micron Technology
MU
$930B
$13.2M 7.18%
155,000
-8,000
-5% -$594K
REGN icon
3
Regeneron Pharmaceuticals
REGN
$78.5B
$10.7M 5.81%
12,200
+1,325
+12% +$1.09M
GOOG icon
4
Alphabet (Google) Class C
GOOG
$4.36T
$9.89M 5.37%
70,150
– –
ARGX icon
5
argenx
ARGX
$53.4B
$7.78M 4.22%
20,450
-1,550
-7% -$722K
SPYM
6
PUT
State Street SPDR Portfolio S&P 500 ETF
SPYM
$161B
$7.66M 4.16%
+137,000
New +$7.18M
ITCI
7
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$6.94M 3.76%
96,857
-10,300
-10% -$593K
AMD icon
8
Advanced Micro Devices
AMD
$776B
$5.6M 3.04%
38,000
-2,700
-7% -$318K
ABBV icon
9
AbbVie
ABBV
$443B
$5.04M 2.73%
32,500
-12,000
-27% -$1.75M
XNCR icon
10
Xencor
XNCR
$1.5B
$5.03M 2.73%
237,107
-9,193
-4% -$175K
ORCL icon
11
Oracle
ORCL
$374B
$4.64M 2.52%
44,000
+1,500
+4% +$164K
GLD icon
12
SPDR Gold Trust
GLD
$131B
$4.4M 2.39%
23,000
+1,500
+7% +$275K
BAC icon
13
Bank of America
BAC
$435B
$4.34M 2.35%
128,750
-750
-0.6% -$21.8K
ET icon
14
Energy Transfer Partners
ET
$70.1B
$4.28M 2.32%
310,000
-63,000
-17% -$856K
LLY icon
15
Eli Lilly
LLY
$1.02T
$4.08M 2.21%
7,000
-500
-7% -$292K
IAU icon
16
iShares Gold Trust
IAU
$62.9B
$3.9M 2.12%
100,000
– –
PRTA icon
17
Prothena Corp
PRTA
$425M
$3.05M 1.66%
84,000
+1,050
+1% +$40.4K
BABA icon
18
Alibaba
BABA
$293B
$2.93M 1.59%
37,800
+16,500
+77% +$1.31M
AAPL icon
19
Apple
AAPL
$4.54T
$2.84M 1.54%
14,750
– –
INCY icon
20
Incyte
INCY
$24.2B
$2.67M 1.45%
42,500
-2,000
-4% -$113K
IWM icon
21
iShares Russell 2000 ETF
IWM
$79.8B
$2.31M 1.25%
11,500
– –
RVNC
22
DELISTED
Revance Therapeutics, Inc.
RVNC
$2.26M 1.23%
256,872
+230,372
+869% +$1.89M
ZBH icon
23
Zimmer Biomet
ZBH
$18.2B
$2.24M 1.22%
18,397
– –
TPB icon
24
Turning Point Brands
TPB
$1.45B
$2.2M 1.19%
83,500
– –
JQC icon
25
Nuveen Credit Strategies Income Fund
JQC
$704M
$2.16M 1.17%
414,000
-6,000
-1% -$30.3K
1
2 3 4 5

Similar funds

JIC
JRM Investment Counsel Omaha, Nebraska $375M AUM 13.43% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
AIM
Access Investment Management Atlanta, Georgia $376M AUM 17.2% 1-Year Est. Return
MWM
McMill Wealth Management Norfolk, Nebraska $376M AUM 14.46% 1-Year Est. Return
RCP
RIT Capital Partners London, United Kingdom $374M AUM 25.18% 1-Year Est. Return
HPM
Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return
CAG
Compass Advisory Group Melville, New York $374M AUM 14.59% 1-Year Est. Return
LWMNY
Landmark Wealth Management (New York) Melville, New York $373M AUM 12.01% 1-Year Est. Return

DCF Advisers's Q4 2023 Portfolio in Review

As of Q4 2023, DCF Advisers held 107 positions worth $184M, up 0.38% from $184M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

DCF Advisers withdrew a net $16.4M in Q4 2023, closing 25 positions and reducing 32 holdings. Its most notable exit was Seagen Inc. Common Stock, an estimated $2.33M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Technology and Communication Services.

Against the trend, DCF Advisers opened a new position in Yeti Holdings worth $518K.

  • DCF Advisers's largest Q4 2023 buy was Yeti Holdings: 10,000 shares worth $518K.
  • DCF Advisers added most to Revance Therapeutics, Inc. in Q4 2023, an estimated $1.89M increase.
  • DCF Advisers's biggest Q4 2023 reduction was AbbVie, cutting an estimated $1.75M.
  • DCF Advisers fully exited Seagen Inc. Common Stock in Q4 2023, selling an estimated $2.33M.
  • DCF Advisers's ten largest holdings make up 51% of its $184M portfolio in Q4 2023.
  • DCF Advisers opened 12 new positions and closed 25 in Q4 2023.
  • DCF Advisers's portfolio value rose 0.38% quarter-over-quarter to $184M.

Based on DCF Advisers's 13F filing for Q4 2023, filed 13 Feb 2024.